Skip to main content
SpringerLink
Log in

Hemorrhagic Cystitis

  • Chapter
  • First Online:
Interventional Urology

Abstract

Hemorrhagic cystitis (HC) is a symptom complex that refers to bleeding caused by an irritation of the bladder mucosa that can be of insidious or rapid onset. This chapter aims to describe the categorization and grading of HC as well as the various etiologies of HC, including infectious, chemical, and radiation-induced HC. Diagnostic criteria for HC are described, with specifications for each etiology of HC. Management options for HC are discussed, ranging from intravesical instillations and other traditional surgical techniques such as cystoscopy/fulguration to novel techniques such as embolization, GAG layer replenishment, fibrin glue, and viral-specific T-cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hong SY, Pyo SJ, Lee HB. Effect of serum urokinase on urine fibrinolytic activity. Nephron. 1990;55(3):287–91.

    CAS  PubMed  Google Scholar 

  2. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology. 1982;20(3):256–8.

    CAS  PubMed  Google Scholar 

  3. Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant. 2015;50(11):1432–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Dosin G, Aoun F, El Rassy E, Assi T, Lewalle P, Blanc J, et al. Viral-induced hemorrhagic cystitis after allogeneic hematopoietic stem cell transplant. Clin Lymphoma Myeloma Leuk. 2017;17(7):438–42.

    PubMed  Google Scholar 

  5. Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010;47(4):306–12.

    PubMed  PubMed Central  Google Scholar 

  6. Boldorini R, Veggiani C, Barco D, Monga G. Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med. 2005;129:69–73.

    PubMed  Google Scholar 

  7. Boldorini R, Veggiani C, Barco D, Monga G. Kidney and urinary tract polyomavirus infection and distribution: molecular biology investigation of 10 consecutive autopsies. Arch Pathol Lab Med. 2005;129(1):69–73.

    PubMed  Google Scholar 

  8. Das D, Shah RB, Imperiale MJ. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene. 2004;23(42):7031–46.

    CAS  PubMed  Google Scholar 

  9. Tan CS, Koralnik IJ. JC, BK, and other polyomaviruses: Progressive multifocal leukoencephalopathy (PML). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier Saunders; 2014. p. 1807–14.e3.

    Google Scholar 

  10. Copelan OR, Sanikommu SR, Trivedi JS, Butler C, Ai J, Ragon BK, et al. Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation. Biol Blood Marrow Transplant. 2019;25(4):785–90.

    PubMed  Google Scholar 

  11. Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis. 1994;169(4):775–81.

    CAS  PubMed  Google Scholar 

  12. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5(3):262–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Carrigan DR. Adenovirus infections in immunocompromised patients. Am J Med. 1997;102(3A):71–4.

    CAS  PubMed  Google Scholar 

  14. Taktak A, Acar B, Gür G, Tiryaki T, Karakuş E, Çaycı FŞ, et al. Cytomegalovirus-related hemorrhagic cystitis in an immunocompetent child. Ren Fail. 2014;36(7):1148–50.

    PubMed  Google Scholar 

  15. Riachy E, Krauel L, Rich BS, McEvoy MP, Honeyman JN, Boulad F, et al. Risk factors and predictors of severity score and complications of pediatric hemorrhagic cystitis. J Urol. 2014;191(1):186–92.

    PubMed  Google Scholar 

  16. Silva Lde P, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica. 2010;95(7):1183–90.

    PubMed  Google Scholar 

  17. Cesaro S, Tridello G, Pillon M, Calore E, Abate D, Tumino M, et al. A prospective study on the predictive value of plasma BK virus-DNA load for hemorrhagic cystitis in pediatric patients after stem cell transplantation. J Pediatric Infect Dis Soc. 2015;4(2):134–42.

    PubMed  Google Scholar 

  18. Mufson MA, Belshe RB. A review of adenoviruses in the etiology of acute hemorrhagic cystitis. J Urol. 1976;115(2):191–4.

    CAS  PubMed  Google Scholar 

  19. Youn IK, Im SA, Lee JW, Chung NG, Cho B. Correlation of the clinical parameters with sonographic findings of hemorrhagic cystitis in pediatric hematooncology patients. Springerplus. 2015;4:577.

    PubMed  PubMed Central  Google Scholar 

  20. Zaleska-Dorobisz U, Biel A, Sokołowska-Dąbek D, Olchowy C, Łasecki M. Ultrasonography in the diagnosis of hemorrhagic cystitis - a complication of bone marrow transplantation in pediatric oncology patients. J Ultrason. 2014;14(58):258–72.

    PubMed  PubMed Central  Google Scholar 

  21. McCarville MB, Hoffer FA, Gingrich JR, Jenkins JJ 3rd. Imaging findings of hemorrhagic cystitis in pediatric oncology patients. Pediatr Radiol. 2000;30(3):131–8.

    CAS  PubMed  Google Scholar 

  22. Schulze M, Beck R, Igney A, Vogel M, Maksimovic O, Claussen CD, et al. Computed tomography findings of human polyomavirus BK (BKV)-associated cystitis in allogeneic hematopoietic stem cell transplant recipients. Acta Radiol. 2008;49(10):1187–94.

    CAS  PubMed  Google Scholar 

  23. Hymes LC, Warshaw BL. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant. 2006;10(8):920–2.

    PubMed  Google Scholar 

  24. Mackey MC. Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. Ann Pharmacother. 2012;46(3):442–6.

    PubMed  Google Scholar 

  25. Ortiz A, Justo P, Sanz A, Melero R, Caramelo C, Guerrero MF, et al. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther. 2005;10(1):185–90.

    CAS  PubMed  Google Scholar 

  26. Meier P, Dautheville-Guibal S, Ronco PM, Rossert J. Cidofovir-induced end-stage renal failure. Nephrol Dial Transplant. 2002;17(1):148–9.

    PubMed  Google Scholar 

  27. Cesaro S, Hirsch HH, Faraci M, Owoc-Lempach J, Beltrame A, Tendas A, et al.; European Group for Blood and Marrow Transplantation. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis. 2009;49(2):233–40.

    Google Scholar 

  28. Schneidewind L, Neumann T, Schmidt CA, Krüger W. Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation-a systematic review. Transpl Infect Dis. 2018;20(4):e12914.

    PubMed  Google Scholar 

  29. Park YH, Lim JH, Yi HG, Lee MH, Kim CS. BK virus-hemorrhagic cystitis following allogeneic stem cell transplantation: clinical characteristics and utility of leflunomide treatment. Turk J Haematol. 2016;33(3):223–30.

    CAS  PubMed Central  Google Scholar 

  30. Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005;352(11):1157–8.

    CAS  PubMed  Google Scholar 

  31. Wu KH, Weng T, Wu HP, Peng CT, Sheu JN, Chao YH. Effective treatment of severe BK virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study. Pediatr Infect Dis J. 2014;33(11):1193–5.

    PubMed  Google Scholar 

  32. Randhawa PS. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis. 2005;41(9):1366–7; author reply 1367.

    PubMed  Google Scholar 

  33. Portolani M, Pietrosemoli P, Cermelli C, Mannini-Palenzona A, Grossi MP, Paolini L, Barbanti-Brodano G. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antivir Res. 1988;9(3):205–18.

    CAS  PubMed  Google Scholar 

  34. Chandraker A, Ali S, Drachenberg CB, Wali R, Hirsch H, DeCaprio J, et al. Use of fluoroquinolones to treat BK infection in renal transplant recipients (abstract). Am J Transplant. 2004;4:587A.

    Google Scholar 

  35. Miller AN, Glode A, Hogan KR, Schaub C, Kramer C, Stuart RK, Costa LJ. Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011;17(8):1176–81.

    CAS  PubMed  Google Scholar 

  36. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32(9):1290–7.

    CAS  PubMed  Google Scholar 

  37. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(7):388–94.

    CAS  PubMed  Google Scholar 

  38. Nakazawa Y, Suzuki T, Fukuyama T, Katsuyama Y, Tanaka M, Yanagisawa R, et al. Urinary excretion of ganciclovir contributes to improvement of adenovirus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation. Pediatr Transplant. 2009;13(5):632–5.

    CAS  PubMed  Google Scholar 

  39. Yanagisawa T, Saito S, Katsuyama Y, Hirabayashi K, Shigemura T, Tanaka M, et al. Successful induction of therapeutic urinary concentration by intravenous ganciclovir and oral valganciclovir with remission of adenoviral hemorrhagic cystitis after cord blood transplantation. Pediatr Transplant. 2018;8:e13241. https://doi.org/10.1111/petr.13241. Epub ahead of print.

    Article  CAS  Google Scholar 

  40. Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J. 2000;19(11):1097–100.

    CAS  PubMed  Google Scholar 

  41. Mo XD, Zhang XH, Xu LP, Wang Y, Yan CH, Chen H, et al. Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroids. Ann Hematol. 2018;97(7):1209–17.

    PubMed  PubMed Central  Google Scholar 

  42. Rodríguez Rodríguez A, Vendrell R, Luque P, López-Alvarado S, Alcaraz A, Carretero P. [Spontaneous bladder perforation secondary to bacterial cystitis. Cause of acute abdomen in diabetic elderly]. Actas Urol Esp. 1995;19(5):393–7. (Article in Spanish).

    Google Scholar 

  43. Ronald AR. Current concepts in the management of urinary tract infections in adults. Med Clin North Am. 1984;68(2):335–49.

    CAS  PubMed  Google Scholar 

  44. Krane D, Levine L. Haemorrhagic cystitis. AUA Update Series. 1992. Vol. XI: Lesson 31.

    Google Scholar 

  45. Schaeffer AJ, Schaeffer EM. Infections of the urinary tract. In: Kavoussi LR, Partin AW, Novick AC, Peters CA, editors. Campbell Walsh urology. 10th ed. Philadelphia: Elsevier; 2012. p. 257–63.

    Google Scholar 

  46. Beyazal Polat H, Beyazal M, Beyazal ÇF. A case report of acute acalculous cholecystitis and acute hemorrhagic cystitis due to Salmonella typhi. Case Rep Med. 2014;2014:758583.

    PubMed  PubMed Central  Google Scholar 

  47. Choi GJ, Kim SJ, Kang JM, Choi SR, Yoo KH, Kim YJ. Severe hematuria in a hematopoietic cell transplant recipient caused by Ureaplasma urealyticum not by BK virus or adenovirus infection. Transpl Infect Dis. 2018;20(4):e12921.

    PubMed  Google Scholar 

  48. Stoller JK. Late recurrence of Mycobacterium bovis genitourinary tuberculosis: case report and review of literature. J Urol. 1985;134(3):565–6.

    CAS  PubMed  Google Scholar 

  49. Haldar S, Dru C, Bhowmick NA. Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2014;2(3):199–208.

    PubMed  PubMed Central  Google Scholar 

  50. Fisher JF, Chew WH, Shadomy S, Duma RJ, Mayhall CG, House WC. Urinary tract infections due to Candida albicans. Rev Infect Dis. 1982;4(6):1107–18.

    CAS  PubMed  Google Scholar 

  51. Neal PM. Schistosomiasis--an unusual cause of ureteral obstruction: a case history and perspective. Clin Med Res. 2004;2(4):216–27.

    PubMed  PubMed Central  Google Scholar 

  52. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Davis CJ. From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation. Radiographics. 2006;26(6):1847–68.

    PubMed  Google Scholar 

  53. Kramer CV, Zhang F, Sinclair D, Olliaro PL. Drugs for treating urinary schistosomiasis. Version 2. Cochrane Database Syst Rev. 2014;2014(8):CD000053.

    PubMed Central  Google Scholar 

  54. Hansman DJ, Brown JM. Eosinophilic cystitis: a case associated with possible hydatid infection. Med J Aust. 1974;2(15):563–5.

    CAS  PubMed  Google Scholar 

  55. Denton AS, Clarke NW, Maher EJ. Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev. 2002;2002(3):CD001773.

    PubMed Central  Google Scholar 

  56. Goodman GB, Hislop TG, Elwood JM, Balfour J. Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys. 1981;7(5):569–73.

    CAS  PubMed  Google Scholar 

  57. Fuentes-Raspall R, Inoriza JM, Rosello-Serrano A, Auñón-Sanz C, Garcia-Martin P, Oliu-Isern G. Late rectal and bladder toxicity following radiation therapy for prostate cancer: predictive factors and treatment results. Rep Pract Oncol Radiother. 2013;18(5):298–303.

    PubMed  PubMed Central  Google Scholar 

  58. Levenback C, Eifel PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994;55(2):206–10.

    CAS  PubMed  Google Scholar 

  59. Martin SE, Begun EM, Samir E, Azaiza MT, Allegro S, Abdelhady M. Incidence and morbidity of radiation-induced hemorrhagic cystitis in prostate cancer. Urology. 2019;131:190–5.

    PubMed  Google Scholar 

  60. Russell NS, Bartelink H. Radiotherapy: the last 25 years. Cancer Treat Rev. 1999;25(6):365–76.

    CAS  PubMed  Google Scholar 

  61. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31(5):1257–80.

    CAS  PubMed  Google Scholar 

  62. Brock N. Oxazaphsophorine cytostatistics: past and present. Cancer Res. 1989;49(a):1–7.

    CAS  PubMed  Google Scholar 

  63. Cox PJ. Cyclophosphamide cystitis--identification of acrolein as the causative agent. Biochem Pharmacol. 1979;28(13):2045–9.

    CAS  PubMed  Google Scholar 

  64. Stillwell TJ, Benson RC Jr. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988;61(3):451–7.

    CAS  PubMed  Google Scholar 

  65. Gray KJ, Engelmann UH, Johnson EH, Fishman IJ. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy. J Urol. 1986;136(2):497–500.

    CAS  PubMed  Google Scholar 

  66. Schoenike SE, Dana WJ. Ifosfamide and mesna. Clin Pharm. 1990;9(3):179–91.

    CAS  PubMed  Google Scholar 

  67. Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol. 2007;23(5):303–12.

    CAS  PubMed  Google Scholar 

  68. Kimura M, Tomita Y, Morishita H, Takahashi K. Presence of mucosal change in the urinary bladder in nonhematuric patients with long-term exposure and/or accumulating high-dose cyclophosphamide. Possible significance of follow-up cystoscopy on preventing development of cyclophosphamide-induced hemorrhagic cystitis. Urol Int. 1998;61(1):8–11.

    CAS  PubMed  Google Scholar 

  69. Dorr RT. Chemoprotectants for cancer chemotherapy. Semin Oncol. 1991;18(1 Suppl 2):48–58.

    CAS  PubMed  Google Scholar 

  70. Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol. 1993 Jul;11(7):1306–10.

    CAS  PubMed  Google Scholar 

  71. Hadjibabaie M, Alimoghaddam K, Shamshiri AR, Iravani M, Bahar B, Mousavi A, et al. Continuous bladder irrigation prevents hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Urol Oncol. 2008;26(1):43–6.

    PubMed  Google Scholar 

  72. Jiang Q, Huang H, Liu Q, Sun J, Zhou H, Fan Z, et al. Continuous IV infusion of MESNA can prevent hemorrhagic cystitis in HSCT and retain MESNA concentration in urine. Bone Marrow Transplant. 2015;50(11):1490–2.

    CAS  PubMed  Google Scholar 

  73. Batista CK, Mota JM, Souza ML, Leitão BT, Souza MH, Brito GA, et al. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. Cancer Chemother Pharmacol. 2007;59(1):71–7.

    CAS  PubMed  Google Scholar 

  74. Matz EL, Hsieh MH. Review of advances in uroprotective agents for cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis. Urology. 2017;100:16–9.

    PubMed  Google Scholar 

  75. Tsuboi K, Kishi K, Ohmachi K, Yasuda Y, Shimizu T, Inoue H, et al. Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32(9):903–7.

    CAS  PubMed  Google Scholar 

  76. Ansari M, Théoret Y, Rezgui MA, Peters C, Mezziani S, Desjean C, et al.; Pediatric Disease Working Parties of the European Blood and Marrow Transplant Group. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation. Ther Drug Monit. 2014;36(1):93–9.

    Google Scholar 

  77. Komiya I, Nojiri M, Kuriya S, Saito Y. Hemorrhagic cystitis caused by bleomycin treatment. Jpn J Med. 1991;30(4):392.

    CAS  PubMed  Google Scholar 

  78. Cantwell BM, Harris AL, Patrick D, Hall RR. Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer. Cancer Treat Rep. 1986;70(4):548–9.

    CAS  PubMed  Google Scholar 

  79. Islam R, Isaacson BJ, Zickerman PM, Ratanawong C, Tipping SJ. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report. Am J Clin Oncol. 2002;25(5):513–4.

    PubMed  Google Scholar 

  80. Ntekim AI, Ajekigbe A. Hemorrhagic cystitis in a patient receiving docetaxel for prostate cancer. Clin Med Insights Oncol. 2010;4:11–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Grellety T, Houédé N, Hoepffner JL, Rivière J, Mérino C, Lieutenant V, et al. Hemorrhagic cystitis in patients treated with cabazitaxel: a radiation recall syndrome? Ann Oncol. 2014;25(6):1248–9.

    CAS  PubMed  Google Scholar 

  82. Laterza MM, Chiurazzi B, Brangi M, Riccardi F, Cartenì G. Gefitinib in non-small cell lung carcinoma: a case report of an unusual side effect and complete response in advanced disease. Tumori. 2013;99(1):3e–5e.

    PubMed  Google Scholar 

  83. Ichioka E, Iguchi-Manaka A, Oikawa T, Sawa A, Okazaki M, Saito T, et al. A case of hemorrhagic cystitis caused by nab-paclitaxel. Int Cancer Conf J. 2016;5(4):187–91.

    PubMed  PubMed Central  Google Scholar 

  84. Marx CM, Alpert SE. Ticarcillin-induced cystitis. Cross-reactivity with related penicillins. Am J Dis Child. 1984;138(7):670–2.

    CAS  PubMed  Google Scholar 

  85. Bracis R, Sanders CV, Gilbert DN. Methicillin hemorrhagic cystitis. Antimicrob Agents Chemother. 1977;12(3):438–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Cook FV, Farrar WE Jr, Kreutner A. Hemorrhagic cystitis and ureteritis, and interstitial nephritis associated with administration of penicillin G. J Urol. 1979;122(1):110–1.

    CAS  PubMed  Google Scholar 

  87. Adlam D, Firoozan S, Gribbin B, Banning AP. Haemorrhagic cystitis and renal dysfunction associated with high dose benzylpenicillin. J Infect. 2000;40(1):102–3.

    CAS  PubMed  Google Scholar 

  88. Toma Y, Ishiki T, Nagahama K, Okumura K, Kamiyama T, Kohagura K, et al. Penicillin G-induced hemorrhagic cystitis with hydronephrosis. Intern Med. 2009;48(18):1667–9.

    PubMed  Google Scholar 

  89. Kim MK, Kang CK, Kim MJ, Jun KI, Lee YK, Jeong SJ, Song KH. Penicillin G-induced hemorrhagic cystitis: a case and review of the literature. Korean J Intern Med. 2013;28(6):743–5.

    PubMed  PubMed Central  Google Scholar 

  90. Andriole GL, Brickman C, Lack EE, Sesterhenn IA, Javadpour N, Linehan WM, Frank MM. Danazol-induced cystitis: an undescribed source of hematuria in patients with hereditary angioneurotic edema. J Urol. 1986;135(1):44–6.

    CAS  PubMed  Google Scholar 

  91. Crawford ML, Waller PC, Wood SM. Severe cystitis associated with tiaprofenic acid. Br J Urol. 1997;79(4):578–84.

    CAS  PubMed  Google Scholar 

  92. Mayersak JS, Viviano CJ. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management. J Urol. 1993;149(4):835–7.

    CAS  PubMed  Google Scholar 

  93. Pliskin MJ, Dresner ML. Inadvertent urethral insertion of a contraceptive suppository. J Urol. 1988;139(5):1049–50.

    CAS  PubMed  Google Scholar 

  94. Nellans RE, Ellis LR, Kenny GM. Ether cystitis. JAMA. 1985;254(4):530.

    CAS  PubMed  Google Scholar 

  95. Lebowitz RL, Effmann EL. Ether cystitis. Urology. 1978;12(4):427–8.

    CAS  PubMed  Google Scholar 

  96. Lyons JS. Hematuria in workmen in aniline dye industry due to 5-chloro-ortho-toluidine; six case reports. J Urol. 1947;58(4):277–81.

    CAS  PubMed  Google Scholar 

  97. Song P, Li X, Yan Y. [Analysis of the literature on acute aromatic amino or nitro-compounds poisoning]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2014 ;32(5):366–9. (Article in Chinese).

    Google Scholar 

  98. Jurincic C, Horlbeck R, Metz K, Klippel KF. [Acute hemorrhagic cystitis following chlordimeform poisoning]. Dtsch Med Wochenschr. 1991;116(21):816–8. (Article in German).

    Google Scholar 

  99. Jain M, Palmo D, Agrawal V, Garg PK. Hemorrhagic cystitis: a rare manifestation of organophosphate poisoning. Urol Ann. 2014;6(3):271–2.

    PubMed  PubMed Central  Google Scholar 

  100. Chen CH, Lee MH, Chen YC, Lin MF. Ketamine-snorting associated cystitis. J Formos Med Assoc. 2011;110(12):787–91.

    CAS  PubMed  Google Scholar 

  101. Ostroff EB, Chenault OW Jr. Alum irrigation for the control of massive bladder hemorrhage. J Urol. 1982;128(5):929–30.

    CAS  PubMed  Google Scholar 

  102. Goel AK, Rao MS, Bhagwat AG, Vaidyanathan S, Goswami AK, Sen TK. Intravesical irrigation with alum for the control of massive bladder hemorrhage. J Urol. 1985;133(6):956–7.

    CAS  PubMed  Google Scholar 

  103. Westerman ME, Boorjian SA, Linder BJ. Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation. Int Braz J Urol. 2016;42(6):1144–9.

    PubMed  PubMed Central  Google Scholar 

  104. Perazella M, Brown E. Acute aluminum toxicity and alum bladder irrigation in patients with renal failure. Am J Kidney Dis. 1993;21(1):44–6.

    CAS  PubMed  Google Scholar 

  105. Phelps KR, Naylor K, Brien TP, Wilbur H, Haqqie SS. Encephalopathy after bladder irrigation with alum: case report and literature review. Am J Med Sci. 1999;318(3):181–5.

    CAS  PubMed  Google Scholar 

  106. Rastinehad AR, Kavoussi LR, Noble MJ. Hemorrhagic cystitis. AUA update series. 2007. Vol. 26: Lesson 31.

    Google Scholar 

  107. Singh I, Laungani GB. Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology. 1992;40(3):227–9.

    CAS  PubMed  Google Scholar 

  108. Rabinovitch HH. Simple innocuous treatment of massive cyclophosphamide hemorrhagic cystitis. Urology. 1979;13(6):610–2.

    CAS  PubMed  Google Scholar 

  109. Ohhara M, Okumura S, Tsuboi N, Kanamori S, Yoshida K, Nishimura T, et al. [Severe cyclophosphamide hemorrhagic cystitis controlled with transurethral electrocoagulation: a case report]. Hinyokika Kiyo. 1985;31(6):1045–8. (Article in Japanese).

    Google Scholar 

  110. Kaplan JR, Wolf JS Jr. Efficacy and survival associated with cystoscopy and clot evacuation for radiation or cyclophosphamide induced hemorrhagic cystitis. J Urol. 2009;181(2):641–6.

    PubMed  Google Scholar 

  111. Gweon P, Shanberg A. Treatment of cyclophosphamide induced hemorrhagic cystitis with neodymium:YAG laser in pediatric patients. J Urol. 1997;157(6):2301–2.

    CAS  PubMed  Google Scholar 

  112. Ravi R. Endoscopic neodymium:YAG laser treatment of radiation-induced hemorrhagic cystitis. Lasers Surg Med. 1994;14(1):83–7.

    CAS  PubMed  Google Scholar 

  113. Talab SS, McDougal WS, Wu CL, Tabatabaei S. Mucosa-sparing, KTP laser coagulation of submucosal telangiectatic vessels in patients with radiation-induced cystitis: a novel approach. Urology. 2014;84(2):478–83.

    PubMed  Google Scholar 

  114. Quinlan DM, Naslund MJ, Brendler CB. Application of argon beam coagulation in urological surgery. J Urol. 1992;147(2):410–2.

    CAS  PubMed  Google Scholar 

  115. Suzuki S, Chino A, Fukui I, Hayashi T, Kozuka T, Suganuma T, et al. Successful use of endoscopic argon plasma coagulation for hemorrhagic radiation cystitis: a case report. Jpn J Clin Oncol. 2014;44(7):692–5.

    PubMed  Google Scholar 

  116. Zhu J, Xue B, Shan Y, Yang D, Zang Y. Transurethral coagulation for radiation-induced hemorrhagic cystitis using Greenlight™ potassium-titanyl-phosphate laser. Photomed Laser Surg. 2013;31(2):78–81.

    PubMed  Google Scholar 

  117. Pascoe C, Christidis D, Manning TG, Lamb BW, Murphy DG, Lawrentschuk N. Photoselective vaporization of the bladder for the management of radiation cystitis-technique and initial outcomes. Urology. 2019;123:295.

    PubMed  Google Scholar 

  118. Martinez DR, Ercole CE, Lopez JG, Parker J, Hall MK. A novel approach for the treatment of radiation-induced hemorrhagic cystitis with the Greenlight™ XPS laser. Int Braz J Urol. 2015;41(3):584–7.

    PubMed  PubMed Central  Google Scholar 

  119. Likourinas M, Cranides A, Jiannopoulos B, Kostakopoulos A, Dimopoulos C. Intravesical formalin for the control of intractable bladder haemorrhage secondary to radiation cystitis or bladder cancer. Urol Res. 1979;7(2):125–6.

    CAS  PubMed  Google Scholar 

  120. Shah BC, Albert DJ. Intravesical instillation of formalin for the management of intractable hematuria. J Urol. 1973;110(5):519–20.

    CAS  PubMed  Google Scholar 

  121. Brown RB. A method of management of inoperable carcinoma of the bladder. Med J Aust. 1969;1(1):23–4.

    CAS  PubMed  Google Scholar 

  122. Choong SK, Walkden M, Kirby R. The management of intractable haematuria. BJU Int. 2000;86(9):951–9.

    CAS  PubMed  Google Scholar 

  123. Ziegelmann MJ, Boorjian SA, Joyce DD, Montgomery BD, Linder BJ. Intravesical formalin for hemorrhagic cystitis: a contemporary cohort. Can Urol Assoc J. 2017;11(3–4):E79–82.

    PubMed  PubMed Central  Google Scholar 

  124. Spiro LH, Hecht H, Horowitz A, Orkin L. Formalin treatment for massive bladder hemorrhage. Complications. Urology. 1973;2(6):669–71.

    CAS  PubMed  Google Scholar 

  125. Godec CJ, Gleich P. Intractable hematuria and formalin. J Urol. 1983;130(4):688–91.

    CAS  PubMed  Google Scholar 

  126. Rao MS, Singhal PC, Bapna BC, Vaidyanathan S, Chugh KS, Bhat VN, et al. Fatal complication of intravesical formalin during control of intractable hemorrhage from radiation cystitis. Urology. 1978;11(6):588–90.

    CAS  PubMed  Google Scholar 

  127. Chugh KS, Singhal PC, Banerjee SS. Acute tubular necrosis following intravesical instillation of formalin. Urol Int. 1977;32(6):454–9.

    CAS  PubMed  Google Scholar 

  128. Kalish M, Silber SJ, Herwig KR. Papillary necrosis. Result of intravesical instillation of formalin. Urology. 1973;2(3):315–7.

    CAS  PubMed  Google Scholar 

  129. Scott MP Jr, Marshall S, Lyon RP. Bladder rupture following formalin therapy for hemorrhage secondary to cyclophosphamide therapy. Urology. 1974;3(3):364–5.

    PubMed  Google Scholar 

  130. Finkelstein LH, Arsht DB, Trenkle D. Vesicoileal fistula: an unusual complication following the use of formalin for control of refractory post-irradiation bladder hemorrhage. J Urol. 1977;117(2):168–70.

    CAS  PubMed  Google Scholar 

  131. Lourie JA, Drysdale HC, Wynne EJ. Death following intravesical formalin instillation. Br J Urol. 1977;49(6):476.

    CAS  PubMed  Google Scholar 

  132. Lojanapiwat B, Sripralakrit S, Soonthornphan S, Wudhikarn S. Intravesicle formalin instillation with a modified technique for controlling haemorrhage secondary to radiation cystitis. Asian J Surg. 2002;25(3):232–5.

    CAS  PubMed  Google Scholar 

  133. Kumar AP, Wrenn EL Jr, Jayalakshmamma B, Conrad L, Quinn P, Cox C. Silver nitrate irrigation to control bladder hemorrhage in children receiving cancer therapy. J Urol. 1976;116(1):85–6.

    CAS  PubMed  Google Scholar 

  134. Raghavaiah NV, Soloway MS. Anuria following silver nitrate irrigation for intractable bladder hemorrhage. J Urol. 1977;118(4):681–2.

    CAS  PubMed  Google Scholar 

  135. Susan LP, Marsh RJ. Phenolization of bladder in treatment of massive intractable hematuria. Urology. 1975;5(1):119–21.

    CAS  PubMed  Google Scholar 

  136. Lebowitz RL. Intravesical chemical cauterization and methemoglobinemia. Pediatrics. 1980;65(3):630.

    CAS  PubMed  Google Scholar 

  137. Levine LA, Jarrard DF. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine. J Urol. 1993;149(4):719–23.

    CAS  PubMed  Google Scholar 

  138. Mohiuddin J, Prentice HG, Schey S, Blacklock H, Dandona P. Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. Ann Intern Med. 1984;101(1):142.

    CAS  PubMed  Google Scholar 

  139. Trigg ME, O'Reilly J, Rumelhart S, Morgan D, Holida M, de Alarcon P. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol. 1990;143(1):92–4.

    CAS  PubMed  Google Scholar 

  140. Shurafa M, Shumaker E, Cronin S. Prostaglandin F2-alpha bladder irrigation for control of intractable cyclophosphamide-induced hemorrhagic cystitis. J Urol. 1987;137(6):1230–1.

    CAS  PubMed  Google Scholar 

  141. Miller LJ, Chandler SW, Ippoliti CM. Treatment of cyclophosphamide-induced hemorrhagic cystitis with prostaglandins. Ann Pharmacother. 1994;28(5):590–4.

    CAS  PubMed  Google Scholar 

  142. Levine LA, Kranc DM. Evaluation of carboprost tromethamine in the treatment of cyclophosphamide-induced hemorrhagic cystitis. Cancer. 1990;66(2):242–5.

    CAS  PubMed  Google Scholar 

  143. Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, et al. Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 1995;46(6):811–5.

    CAS  PubMed  Google Scholar 

  144. Cardinal J, Slade A, McFarland M, Keihani S, Hotaling JN, Myers JB. Scoping review and meta-analysis of hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. Curr Urol Rep. 2018;19(6):38.

    PubMed  Google Scholar 

  145. Oscarsson N, Arnell P, Lodding P, Ricksten SE, Seeman-Lodding H. Hyperbaric oxygen treatment in radiation-induced cystitis and proctitis: a prospective cohort study on patient-perceived quality of recovery. Int J Radiat Oncol Biol Phys. 2013;87(4):670–5.

    CAS  PubMed  Google Scholar 

  146. Connolly SS, D'Arcy FT, Corcoran MO. Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis. Ir J Med Sci. 2010;179(3):431–3.

    CAS  PubMed  Google Scholar 

  147. Geisler JP, Linnemeier GC, Manahan KJ. Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report. J Reprod Med. 2008;53(5):360–2. 3.

    PubMed  Google Scholar 

  148. Demesmay K, Tissot E, Bulabois CE, Bertrand MA, Racadot E, Woronoff-Lemsi MC, et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation. 2002;74(8):1190–2.

    CAS  PubMed  Google Scholar 

  149. Aroney RS, Dalley DN, Levi JA. Haemorrhagic cystitis treated with epsilon-aminocaproic acid. Med J Aust. 1980;2(2):92.

    CAS  PubMed  Google Scholar 

  150. Eigner EB, Freiha FS. The fate of the remaining bladder following supravesical diversion. J Urol. 1990;144(1):31–3.

    CAS  PubMed  Google Scholar 

  151. Fazili T, Bhat TR, Masood S, Palmer JH, Mufti GR. Fate of the leftover bladder after supravesical urinary diversion for benign disease. J Urol. 2006;176(2):620–1.

    PubMed  Google Scholar 

  152. Linder BJ, Tarrell RF, Boorjian SA. Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes. J Urol. 2014;192(6):1687–92.

    PubMed  Google Scholar 

  153. Bae SH, Han DK, Baek HJ, Park SJ, Chang NK, Kook H, Hwang TJ. Selective embolization of the internal iliac arteries for the treatment of intractable hemorrhage in children with malignancies. Korean J Pediatr. 2011;54(4):169–75.

    PubMed  PubMed Central  Google Scholar 

  154. Palandri F, Bonifazi F, Rossi C, Falcioni S, Arpinati M, Giannini MB, et al. Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplant. 2005;35(5):529–30.

    CAS  PubMed  Google Scholar 

  155. Giné E, Rovira M, Real I, Burrel M, Montaña J, Carreras E, Montserrat E. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant. 2003;31(10):923–5.

    PubMed  Google Scholar 

  156. Cho CL, Lai MH, So HS, Kwok KK, Chan JC, Velayudhan V. Superselective embolisation of bilateral superior vesical arteries for management of haemorrhagic cystitis. Hong Kong Med J. 2008;14(6):485–8.

    CAS  PubMed  Google Scholar 

  157. Mohan S, Kumar S, Dubey D, Phadke RV, Baijal SS, Kathuria M. Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. World J Urol. 2019;37(10):2175–82.

    PubMed  Google Scholar 

  158. Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int. 2012;109(5):691–4.

    PubMed  Google Scholar 

  159. Thompson A, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, et al. Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis. J Clin Urol. 2014;7(1):25–35.

    Google Scholar 

  160. Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate in chronic forms of cystitis. A multi-national, multi-centre, prospective observational clinical trial. Arzneimittelforschung. 2008;58(7):328–35.

    CAS  PubMed  Google Scholar 

  161. Wang Y, Chen F, Gu B, Chen G, Chang H, Wu D. Mesenchymal stromal cells as an adjuvant treatment for severe late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Acta Haematol. 2015;133(1):72–7.

    CAS  PubMed  Google Scholar 

  162. Tong J, Liu H, Zheng C, Zhu X, Tang B, Wan X, et al. Effects and long-term follow-up of using umbilical cord blood-derived mesenchymal stromal cells in pediatric patients with severe BK virus-associated late-onset hemorrhagic cystitis after unrelated cord blood transplantation. Pediatr Transplant. 2020;24(2):e13618.

    CAS  PubMed  Google Scholar 

  163. Aronsson-Kurttila W, Baygan A, Moretti G, Remberger M, Khoein B, Moll G, et al. Placenta-derived decidua stromal cells for hemorrhagic cystitis after stem cell transplantation. Acta Haematol. 2018;139(2):106–14.

    CAS  PubMed  Google Scholar 

  164. Apiwattanakul N, Hongeng S, Anurathapan U, Pakakasama S, Srisala S, Techasaensiri C, Andersson BS. Viral-specific T-cell response in hemorrhagic cystitis after haploidentical donor stem cell transplantation. Transpl Infect Dis. 2017;19(6) https://doi.org/10.1111/tid.12775.

  165. Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35(31):3547–57.

    CAS  PubMed  PubMed Central  Google Scholar 

  166. Masieri L, Sessa F, Mari A, Campi R, Cito G, Verrienti P, et al. Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single-centre preliminary experience. Int Urol Nephrol. 2019;51(10):1715–20.

    CAS  PubMed  Google Scholar 

  167. Purves JT, Graham ML, Ramakumar S. Application of fibrin glue to damaged bladder mucosa in a case of BK viral hemorrhagic cystitis. Urology. 2005;66(3):641–3.

    PubMed  Google Scholar 

  168. Tirindelli MC, Flammia GP, Bove P, Cerretti R, Cudillo L, De Angelis G, et al.; Rome Transplant Network. Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20(10):1612–7.

    Google Scholar 

  169. Bove P, Iacovelli V, Tirindelli MC, Bianchi D, Flammia GP, Cipriani C, et al. Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: a single cohort pilot study. J Endourol. 2019;33(2):93–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Mayo Clinic Jacksonville, Jacksonville, FL, USA

    Ethan Wajswol

  2. Department of Diagnostic, Molecular and Interventional Radiology, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Aaron M. Fischman

  3. Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA

    Jeffrey W. Nix

Authors
  1. Ethan Wajswol
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aaron M. Fischman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey W. Nix
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey W. Nix .

Editor information

Editors and Affiliations

  1. Urology and Radiology, Lenox Hill Hospital, New York, NY, USA

    Ardeshir R. Rastinehad

  2. Vascular & Interventional Radiology, North Shore Long Island Jewish Health System, New Hyde Park, NY, USA

    David N. Siegel

  3. National Cancer Institute & Clinica, Bethesda, MD, USA

    Bradford J. Wood

  4. Lefrak Center for Robotic Surgery, Weill Cornell Medicine, New York, NY, USA

    Timothy McClure

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wajswol, E., Fischman, A.M., Nix, J.W. (2021). Hemorrhagic Cystitis. In: Rastinehad, A.R., Siegel, D.N., Wood, B.J., McClure, T. (eds) Interventional Urology . Springer, Cham. https://doi.org/10.1007/978-3-030-73565-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-73565-4_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-73564-7

  • Online ISBN: 978-3-030-73565-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation